| Primary |
| Product Used For Unknown Indication |
50.0% |
| Pain |
37.5% |
| Back Pain |
12.5% |
|
| Toxicity To Various Agents |
37.5% |
| Product Quality Issue |
25.0% |
| Skin Exfoliation |
12.5% |
| Urticaria |
12.5% |
| Vomiting |
12.5% |
|
| Secondary |
| Pain |
38.5% |
| Product Used For Unknown Indication |
38.5% |
| Back Pain |
10.3% |
| Abdominal Pain |
5.1% |
| Pancreatitis Relapsing |
5.1% |
| Breakthrough Pain |
2.6% |
|
| Intentional Overdose |
28.6% |
| Incorrect Route Of Drug Administration |
14.3% |
| Paraesthesia |
14.3% |
| Toxicity To Various Agents |
14.3% |
| Trigeminal Neuralgia |
14.3% |
| Vomiting |
14.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.8% |
| Pain |
12.8% |
| Contraception |
9.8% |
| Drug Use For Unknown Indication |
5.6% |
| Nausea |
4.4% |
| Depression |
3.6% |
| Acne |
3.3% |
| Crohn's Disease |
3.3% |
| Anxiety |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Hypersensitivity |
3.1% |
| Hypertension |
3.1% |
| Diabetes Mellitus |
2.9% |
| Premenstrual Syndrome |
2.9% |
| Migraine |
2.3% |
| Asthma |
2.1% |
| Prophylaxis |
2.1% |
| Plasma Cell Myeloma |
1.9% |
| Premenstrual Dysphoric Disorder |
1.9% |
| Constipation |
1.7% |
|
| Pulmonary Embolism |
34.6% |
| Pain |
10.8% |
| Deep Vein Thrombosis |
8.5% |
| Vomiting |
5.4% |
| Weight Decreased |
5.4% |
| Pain In Extremity |
3.8% |
| Thrombosis |
3.8% |
| Tremor |
3.8% |
| Psychological Trauma |
3.1% |
| Thrombophlebitis Superficial |
3.1% |
| International Normalised Ratio Increased |
2.3% |
| Vena Cava Thrombosis |
2.3% |
| Vitamin D Deficiency |
2.3% |
| Colitis Ischaemic |
1.5% |
| Gallbladder Disorder |
1.5% |
| Pancreatitis |
1.5% |
| Scar |
1.5% |
| Sinusitis |
1.5% |
| Upper Limb Fracture |
1.5% |
| Urinary Hesitation |
1.5% |
|